INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related ...
INVESTORS & MEDIA · News Releases · Twitter Feed · Quick Links · Subscribe for updates from inovio · Email Alerts · Email Alert Sign Up Confirmation.
People also ask
Is Ino a good stock to buy now?
Did Inovio stock split?
Who are the shareholders of Ino?
What do Inovio pharmaceuticals do?
Find annual and quearterly earnings data for Inovio Pharmaceuticals, Inc. Common Stock (INO) including earnings per share, earnings forecasts at Nasdaq.com.
(INO). Follow. 10.16 -0.21 (-2.03%). At close: 4:00 ... Manager of Investor Relations, --, --, --. Mr. Robert ... Its products in pipeline include VGX-3100 for the ...
The Investor Relations website contains information about Inozyme Pharma, Inc.'s business for stockholders, potential investors, and financial analysts.
Missing: ino | Show results with:ino
Get the latest insights on Inovio Pharmaceuticals, Inc. Common Stock (INO) with press releases and corporate news to help you in your trading and investing ...
Jan 8, 2024 · This presentation includes statements that are, or may be deemed, “forward-looking statements,”” within the meaning of Section 27A of the ...
Missing: relations | Show results with:relations
Mar 6, 2024 · Please go ahead. Thomas Hong -- Investor Relations Manager. Good afternoon and thank you for joining the Inovio 2023 fourth-quarter and full- ...
Inovio Pharmaceuticals (INO) Earnings Dates & Reports - Tipranks
www.tipranks.com › stocks › earnings
Rating
(3,975)
Inovio Pharmaceuticals (INO) will release its next earnings report on May 7, 2024 ... investors and does not represent returns that any investor actually attained ...
Inotiv, Inc., is a leading contract research organization dedicated to providing nonclinical and analytical drug discovery and development services and research ...
Missing: ino | Show results with:ino